-
A Translational, Pharmacodynamic and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer
Study
phs000829
-
National Cancer Institute (NCI) Early Onset Malignancies Initiative (EOMI): Molecular profiling of Breast, Colon, Kidney, Liver, Multiple Myeloma, and Prostate among Racially and Ethnically Diverse Populations
Study
phs001952
-
single cell data from HPV-positive head and neck cancer patients receiving induction CTLA-4 and PD-1 immune checkpoint blockade
Study
EGAS50000000335
-
Enhancer profiling identifies epigenetic markers of endocrine resistance and reveals therapeutic options for metastatic castration-resistant prostate cancer patients (LuCaP cell line data)
Study
EGAS50000000917
-
HSC_population_dynamics_KSP_samples
Study
EGAS00001002762
-
MutWP6__CRUK_Grand_Challenge_Mutographs_of_Cancer__Botseq
Study
EGAS00001004330
-
COMPASS Next Generation Sequencing WGS data
Study
EGAS50000001091
-
UCL Translation Uro-Oncology Data Access Committee will govern access to data generated from the Translation Uro-Oncology groups of the UCL Cancer Institute and UCL Division of Surgery & Interventional Science
Dac
EGAC00001000471
-
Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study
Study
EGAS50000001032
-
Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration
Study
phs003396
-
The Haplotype-Resolved Genome and Epigenome of the Aneuploid HeLa Cancer Cell Line
Study
phs000642
-
DNA Repair Capacity for Lung Disease Risk Assessment
Study
phs004063
-
APOBEC Mutagenesis, Kataegis, Chromothripsis in EGFR-Mutant Osimertinib-Resistant Lung Adenocarcinomas
Study
phs003812
-
HeLa Cell Genome Sequencing Studies
Study
phs000640
-
Tumor-associated neutrophil 1 precursors impair homologous DNA repair and promote sensitivity to PARP-inhibition
Study
EGAS00001008154
-
WES data of pediatric cancer patients with P/LP variants in HBOC-related genes
Dataset
EGAD50000001561
-
Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma
Study
EGAS50000000870
-
University of Sydney Thyroid Cancer Data Access Committee
Dac
EGAC50000000661
-
Biomarker Research for Anti EGFR Monoclonal Antibodies by Comprehensive Cancer Genomics
Study
JGAS000779
-
Identification of colorectal cancer susceptibility genes in Japanese
Study
JGAS000699
-
Developing therapeutics for ovarian cancer using ovarian cancer organoids
Study
JGAS000764
-
Elucidating the development of cervical cancer and identifying therapeutic targets based on cancer genome analysis.
Study
JGAS000803
-
Application of organoid culture system of human gastrointestinal and thoracic cancer in genome medicine
Study
JGAS000749
-
Atezolizumab monotherapy following dCRT indicated a promising cCR rate in patients with unresectable locally advanced esophageal squamous cell carcinoma (EPOC1802)
Study
JGAS000708
-
Evaluation of novel therapies using primary cultured gynecological cancer cells and search for predictors of efficacy
Study
JGAS000809
-
Application of targeted long-read methylation sequencing to dissected breast cancer tissues
Study
JGAS000758
-
Identification of gastric cancer susceptibility genes in Japanese
Study
JGAS000698
-
PD-1 antibody-bound progenitor-exhausted CD8+ T cells in lymph nodes boost PD-1-blockade anti-tumor immunity in gastrointestinal cancer
Study
JGAS000720
-
Elucidation of the association of the HPV integration and oropharyngeal cancer
Study
JGAS000751
-
Development of actionable molecular targets and/or biomarkers for prognostication and patient stratification in gynecological cancer based on whole-exome sequencing and epigenomic analysis
Study
JGAS000642
-
Application of organoid culture system of human gastrointestinal and thoracic cancer in genome medicine
Study
JGAS000664
-
Transcriptome sequencing of human colon organoid after co-cultivation with Bifidobacterium longum
Study
JGAS000740
-
RNA sequencing of surgically removed lung adenocarcinoma afterwards treated with immune checkpoint inhibitors
Study
JGAS000675
-
1. Identidication of molecular biological mechanism associated with the development and prognosis of uterine cancer, uterine sarcoma, and endometrial hyperplasia / 2. Identification of molecular biological mechanism associated with the development of endometriosis and malignant transformation, ovarian cancer, fallopian tubal cancer, peritoneal cancer, and other malignant tumors in gynecological organs
Study
JGAS000789
-
Spatial omics analysis of non-small cell lung cancers for revealing molecular statuses of intratumor heterogeneity and tumor microenvironment
Study
JGAS000613
-
Whole genome sequencing data using Adaptive sampling from 33 patients with hereditary cancer syndrome
Study
JGAS000654
-
Prevalence of rare pathogenic variants in cancer-predisposing genes among Japanese advanced prostate cancer patients.
Study
JGAS000509
-
Whole exome sequence in EGFR-TKI resistant non-small cell lung cancer
Study
JGAS000102
-
Identification of gastric cancer susceptibility genes in Japanese
Study
JGAS000701
-
Exploring Genomic Mutations in Gastric Cancer among Japanese Populations
Study
JGAS000754
-
Amplicon sequencing of long non-coding RNA associated with gastritis and gastric carcinogenesis
Study
JGAS000353
-
Multi-omic profiling of patient-derived pancreatic tumor organoids
Study
JGAS000719
-
Application of organoid culture system of human gastrointestinal and thoracic cancer in genome medicine
Study
JGAS000641
-
Pilot study towards the development of a Companion/Complimentary Diagnosis platform using liquid biopsy with cfDNA for immune checkpoint inhibitor therapy in advanced urothelial cancer
Study
JGAS000714
-
Application of targeted long-read methylation sequencing to dissected lung cancer tissues
Study
JGAS000757
-
Evaluation of clonal hematopoiesis regarding TP53 mutation status in 140,597 individuals
Study
JGAS000782
-
Amplicon sequencing of various tumors
Study
JGAS000366
-
1. Identidication of molecular biological mechanism associated with the development and prognosis of uterine cancer, uterine sarcoma, and endometrial hyperplasia / 2. Identification of molecular biological mechanism associated with the development of endometriosis and malignant transformation, ovarian cancer, fallopian tubal cancer, peritoneal cancer, and other malignant tumors in gynecological organs
Study
JGAS000560
-
Spatiotemporal single-cell analysis reveals a time-dependent immunological modulation by multi-fractionated radiotherapy in esophageal cancer
Study
JGAS000712
-
scMultiome analysis of human tongue cancer organoids
Study
JGAS000606
-
Trial of Onco-Panel for Geneprofiling to Estimate both Adverse events and Response by cancer treatment (TOP-GEAR)
Study
JGAS000662
-
Single nucleus RNA sequencing of squamous cell carcinoma arising from mature teratoma of the ovary
Study
JGAS000521
-
Application of organoid culture system of human gastrointestinal and thoracic cancer in genome medicine
Study
JGAS000653
-
Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome
Study
JGAS000715
-
Spatial transcroptomic analyses against non-metastatic and metastatic lymph node from breast cancer patients
Study
JGAS000616
-
Spatial transcriptome analysis for elucidating progression of early lung adenocarcinoma
Study
JGAS000677
-
Vaccine-Expanded Plasmablast-like B Cells Are Associated with Response to Dendritic Cell Therapy in Metastatic Melanoma
Study
EGAS50000001177
-
Genomic Rearrangements in Pediatric Cancer
Dataset
EGAD00001007701
-
WGS dataset for Genomic rearrangements in Pediatric Cancer
Dataset
EGAD00001008272
-
Detection of brain cancer using genome-wide cell-free DNA fragmentomes
Study
EGAS50000000986
-
The dataset for Detection of brain cancer using genome-wide cell-free DNA fragmentomes
Dataset
EGAD50000001445
-
Data access committee for "Detection of brain cancer using genome-wide cell-free DNA fragmentomes"
Dac
EGAC50000000605
-
Sensitive neoantigen discovery by real-time mutanome-guided immunopeptidomics - WES
Study
EGAS50000000976
-
Tumor gene project
Study
EGAS50000000984
-
GOSH_Paediatric_Tumour_23P108_WSSS_WGS_Managed_Access
Study
EGAS00001007536
-
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Study
EGAS50000000228
-
Characterization of UV DNA damage in B-cell precursor acute lymphoblastic leukemia
Study
EGAS00001008128
-
Neoantigen Peptides derived from V(D)J-recombined Immunoglobulins Drive Outgrowth of Cytolytic CD8+ T-cells
Study
EGAS00001008229
-
Single Cell RNA-Sequencing of BCG Naive and Recurrent Non-Muscle Invasive Bladder Cancer Reveals a CD6/ALCAM-Mediated Immune-Suppressive Pathway
Study
phs003742
-
Neuroblastoma Smart-Seq2 Single Nuclei Sequencing Data
Study
EGAS50000001103
-
Pancreatic Cancer NGS WGS data
Study
EGAS50000001078
-
Genomic analysis of HGSOC using long read sequencing
Study
EGAS50000001036
-
Oxford Nanopore long-read sequencing data of high-grade serous ovarian cancer
Dataset
EGAD50000001509
-
MD Anderson Cancer Center HGSOC LRS Data Access Comittee
Dac
EGAC50000000597
-
Targeted Sequencing Data for RESOLVE Clinical Trial
Dataset
EGAD50000001711
-
DFCI Gynecological Oncology Data Access Committee
Dac
EGAC50000000712
-
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Study
EGAS00001007404
-
Ontario Institute for Cancer Research; Biliary Tract Cancer
Study
EGAS50000000972
-
WGS data from MTB-Guided Targeted Treatments paper
Dataset
EGAD50000001418
-
Whole Exome Sequencing of Human Gastro-esophageal Cancer PDXs
Study
EGAS50000000966
-
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer
Study
EGAS00001004615
-
Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive, HER2-negative breast cancer patients.
Study
EGAS50000001166
-
Mutational signatures in normal tissues of patients treated with clinical stage G-quadruplex binder CX5461
Study
EGAS50000001145
-
ctDNA multigenic panel for non-small cell lung cancer
Study
EGAS50000000643
-
Re-evaluation of human mitochondrial DNA methylation reveals signals consistent with technical artifacts
Study
EGAS50000001186
-
Dataset of Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive, HER2-negative breast cancer patients.
Dataset
EGAD50000001665
-
Mutational signatures in normal tissues of patients treated with clinical stage G-quadruplex binder CX5461
Dataset
EGAD50000001640
-
NSCLC ctDNA multigenic panel
Dataset
EGAD50000000908
-
DAC Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive, HER2-negative breast cancer patients.
Dac
EGAC50000000694
-
The Formation and Propagation of Human Robertsonian Chromosomes
Study
phs003920
-
Involvement of the FGF8/FGF Receptor Signaling Pathway in the Maintenance and Progression of Fusion-Positive Rhabdomyosarcoma
Study
phs004009
-
Rituximab-treated lymphoma patients show correlated deficiency in serological and T cell Spike-specific response after SARS-CoV-2 vaccination: insights from the CORSA Study.
Study
EGAS50000001205
-
Genomic landscape of poorly differentiated thyroid carcinoma
Study
EGAS50000001134
-
Bulk RNA sequencing data of high-grade serous ovarian cancer samples (set 7-17)
Dataset
EGAD50000001370
-
Somatic L1 retrotransposition dynamics in high-grade serous ovarian cancer
Study
EGAS50000001198
-
Hematopoietic Tet2 inactivation enhances the response to checkpoint blockade immunotherapy
Study
EGAS50000001191
-
Dual inhibition of FLT3 and BCL-2 is effective in preclinical models of BCL11B-activated lineage ambiguous leukemia
Study
EGAS50000000978
-
Translational analyses from a phase II study of pembrolizumab and epigenetic modification with azacitidine in platinum-resistant epithelial ovarian cancer
Study
EGAS50000001165
-
Transcriptomic dataset from a phase II study of pembrolizumab and epigenetic modification with azacitidine in platinum-resistant epithelial ovarian cancer
Dataset
EGAD50000001664
-
Data Access Committee for Translational analyses from a phase II study of pembrolizumab and epigenetic modification with azacitidine in platinum-resistant epithelial ovarian cancer
Dac
EGAC50000000697